Aspen in talks for vaccine licensing in Africa
Pharmaceutical group Aspen received a positive response from the market today following their full-year results. Revenue from continuing operations increased by 12 per cent this year to R37,8 billion. Stephen Saad, Chief Executive, Aspen Group joins CNBC Africa for more.
Thu, 02 Sep 2021 15:28:08 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.
